These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 15639695

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z, Dashti-Khavidaki S, Nasiri-Toosi M, Khalili H, Jafarian A, Irajian H, Abdollahi A, Sadrai S.
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K, Kim YS, Kwon KI, Park MS, Lee YJ, Kim KH.
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [Abstract] [Full Text] [Related]

  • 49. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR, Claes K, Bammens B, Evenepoel P, Vanrenterghem Y.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [Abstract] [Full Text] [Related]

  • 50. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X, Liu ZH, Zheng JM, Chen ZH, Tang Z, Chen JS, Li LS.
    Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
    [Abstract] [Full Text] [Related]

  • 51. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients.
    Zaltzman JS, Boucher A, Busque S, Halloran PF, Landsberg DN, McAlister VC, Russell D, Shoker A, Shapiro J, Tchervenkov JI, Ferguson R.
    Clin Transplant; 2005 Feb; 19(1):26-32. PubMed ID: 15659130
    [Abstract] [Full Text] [Related]

  • 52. Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation.
    Ro H, Min SI, Yang J, Moon KC, Kim YS, Kim SJ, Ahn C, Ha J.
    Ther Drug Monit; 2012 Dec; 34(6):680-5. PubMed ID: 23149441
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 Dec; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, Togashi H, Matsuura S, Tada H, Suzuki T, Habuchi T.
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [Abstract] [Full Text] [Related]

  • 59. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
    Bandur S, Petrasek J, Hribova P, Novotna E, Brabcova I, Viklicky O.
    Transplantation; 2008 Nov 15; 86(9):1206-13. PubMed ID: 19005401
    [Abstract] [Full Text] [Related]

  • 60. High initial blood levels of tacrolimus in overweight renal transplant recipients.
    Rodrigo E, de Cos MA, Sánchez B, Ruiz JC, Piñera C, Fernández-Fresnedo G, Palomar R, Pérez-Ceballos MA, Cotorruelo JG, Zubimendi JA, de Francisco AL, Arias M.
    Transplant Proc; 2005 Apr 15; 37(3):1453-4. PubMed ID: 15866635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.